enGene Holdings Inc. Common Stock (ENGN)
$6.28 -$0.27 (-4.10%) 4:37 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$440.95M -
Day's Range
$6.25 - $6.75 -
Volume
11,391 -
52 Week Low / High
$4.42 - $18.40 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
ENGN's Dividend
Analyists Ranking
- 5
- Strong Buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $35.50
- Target Price
Company News
-
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors — Jul 18th, 2024
NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$